Detalles de la búsqueda
1.
89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer.
Ann Oncol
; 33(1): 80-88, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34736925
2.
Molecular Tumor Boards: current practice and future needs.
Ann Oncol
; 28(12): 3070-3075, 2017 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29045504
3.
Complication rates of CT-guided transthoracic lung biopsy: meta-analysis.
Eur Radiol
; 27(1): 138-148, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27108299
4.
Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: treating the right patients based on individualized treatment effect prediction.
Ann Oncol
; 27(7): 1280-6, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27052652
5.
Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosis.
Ann Oncol
; 26(5): 902-907, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25672893
6.
A randomized phase II study comparing paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV nonsquamous nonsmall-cell lung cancer: NVALT12 (NCT01171170).
Ann Oncol
; 26(11): 2286-93, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26347109
7.
Circulating tumor cells are prognostic in SCLC, but still lack clinical application.
Ann Oncol
; 30(7): 1031-1033, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31095269
8.
Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial.
Ann Oncol
; 25(5): 1044-52, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24585722
9.
Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study.
Acta Oncol
; 58(10): 1528-1531, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31256737
10.
A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study.
Ann Oncol
; 24(11): 2860-5, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23986090
11.
A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC).
Ann Oncol
; 24(9): 2382-9, 2013 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-23788751
12.
Reliability of panel-based mutational signatures for immune-checkpoint-inhibition efficacy prediction in non-small cell lung cancer.
Lung Cancer
; 182: 107286, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37421934
13.
Using genomic scars to select immunotherapy beneficiaries in advanced non-small cell lung cancer.
Sci Rep
; 13(1): 6581, 2023 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37085581
14.
Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trial.
Lung Cancer
; 178: 96-102, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36806899
15.
VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.
Br J Cancer
; 107(11): 1820-5, 2012 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23079575
16.
Treatment and survival of patients with small-cell lung cancer: small steps forward, but not for patients >80.
Ann Oncol
; 23(4): 954-60, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21690233
17.
Copy number alterations assessed at the single-cell level revealed mono- and polyclonal seeding patterns of distant metastasis in a small-cell lung cancer patient.
Ann Oncol
; 28(7): 1668-1670, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28419234
18.
Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor.
Ann Oncol
; 23(11): 2937-2942, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22689177
19.
Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it?
Ann Oncol
; 22(4): 821-826, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20929965
20.
First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging.
Ann Oncol
; 22(3): 559-566, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20702788